Anaplasia in Wilms tumor: A critical review

<p dir="ltr">Anaplasia in Wilms tumor is recognized as the most important prognostically unfavorable histological feature. It is subtyped as focal anaplastic Wilms tumor (FAWT) and diffuse anaplastic Wilms tumor (DAWT). Outcomes of patients with DAWT remain poor in patients with stag...

Full description

Saved in:
Bibliographic Details
Main Author: Gordan M. Vujanić (14778694) (author)
Other Authors: William Mifsud (1394) (author)
Published: 2024
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513542053429248
author Gordan M. Vujanić (14778694)
author2 William Mifsud (1394)
author2_role author
author_facet Gordan M. Vujanić (14778694)
William Mifsud (1394)
author_role author
dc.creator.none.fl_str_mv Gordan M. Vujanić (14778694)
William Mifsud (1394)
dc.date.none.fl_str_mv 2024-04-11T06:00:00Z
dc.identifier.none.fl_str_mv 10.1002/pbc.31000
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Anaplasia_in_Wilms_tumor_A_critical_review/29898509
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
Paediatrics
anaplasia
chemotherapy resistance
COG
diffuse anaplasia
focal anaplasia
SIOP
tumor aggres- siveness
Wilms tumor
dc.title.none.fl_str_mv Anaplasia in Wilms tumor: A critical review
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Anaplasia in Wilms tumor is recognized as the most important prognostically unfavorable histological feature. It is subtyped as focal anaplastic Wilms tumor (FAWT) and diffuse anaplastic Wilms tumor (DAWT). Outcomes of patients with DAWT remain poor in patients with stage III and IV tumors. Important issues relevant to anaplasia in Wilms tumor, including prevalence, treatment, outcomes, biomarkers, anaplasia, and chemotherapy, and the concept of tumor aggressiveness, are reviewed and discussed here. We also consider the differences in clinical approaches to anaplasia in Wilms tumor between the two major renal tumor clinical research groups: the International Society of Paediatric Oncology (SIOP) Renal Tumour Study Group and the Children's Oncology Group (COG) Renal Tumor Group. We emphasize the importance and implications of recognizing FAWT and DAWT as separate clinico‐pathological entities.</p><h2>Other Information</h2><p dir="ltr">Published in: Pediatric Blood & Cancer<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/pbc.31000" target="_blank">https://dx.doi.org/10.1002/pbc.31000</a></p>
eu_rights_str_mv openAccess
id Manara2_cb9fc1d0e52353ebb946f55dd7638be5
identifier_str_mv 10.1002/pbc.31000
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29898509
publishDate 2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Anaplasia in Wilms tumor: A critical reviewGordan M. Vujanić (14778694)William Mifsud (1394)Biomedical and clinical sciencesClinical sciencesOncology and carcinogenesisPaediatricsanaplasiachemotherapy resistanceCOGdiffuse anaplasiafocal anaplasiaSIOPtumor aggres- sivenessWilms tumor<p dir="ltr">Anaplasia in Wilms tumor is recognized as the most important prognostically unfavorable histological feature. It is subtyped as focal anaplastic Wilms tumor (FAWT) and diffuse anaplastic Wilms tumor (DAWT). Outcomes of patients with DAWT remain poor in patients with stage III and IV tumors. Important issues relevant to anaplasia in Wilms tumor, including prevalence, treatment, outcomes, biomarkers, anaplasia, and chemotherapy, and the concept of tumor aggressiveness, are reviewed and discussed here. We also consider the differences in clinical approaches to anaplasia in Wilms tumor between the two major renal tumor clinical research groups: the International Society of Paediatric Oncology (SIOP) Renal Tumour Study Group and the Children's Oncology Group (COG) Renal Tumor Group. We emphasize the importance and implications of recognizing FAWT and DAWT as separate clinico‐pathological entities.</p><h2>Other Information</h2><p dir="ltr">Published in: Pediatric Blood & Cancer<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/pbc.31000" target="_blank">https://dx.doi.org/10.1002/pbc.31000</a></p>2024-04-11T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/pbc.31000https://figshare.com/articles/journal_contribution/Anaplasia_in_Wilms_tumor_A_critical_review/29898509CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/298985092024-04-11T06:00:00Z
spellingShingle Anaplasia in Wilms tumor: A critical review
Gordan M. Vujanić (14778694)
Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
Paediatrics
anaplasia
chemotherapy resistance
COG
diffuse anaplasia
focal anaplasia
SIOP
tumor aggres- siveness
Wilms tumor
status_str publishedVersion
title Anaplasia in Wilms tumor: A critical review
title_full Anaplasia in Wilms tumor: A critical review
title_fullStr Anaplasia in Wilms tumor: A critical review
title_full_unstemmed Anaplasia in Wilms tumor: A critical review
title_short Anaplasia in Wilms tumor: A critical review
title_sort Anaplasia in Wilms tumor: A critical review
topic Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
Paediatrics
anaplasia
chemotherapy resistance
COG
diffuse anaplasia
focal anaplasia
SIOP
tumor aggres- siveness
Wilms tumor